Position in FLGT
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$687,420
New position
Shares Held
43,234
first reported quarter
Ownership
0.152%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026LEVIN CAPITAL STRATEGIES, L.P. holds $20,528,370 across 6 Diagnostics & Research names. FLGT ranks #5 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | WAT |
Waters Corp /De/
|
29,535 | $8,795,523 | |
| 2 | LH |
Labcorp Holdings Inc.
|
21,013 | $5,606,478 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
6,291 | $3,092,215 | |
| 4 | DGX |
Quest Diagnostics Inc
|
8,500 | $1,665,830 | |
| 5 | FLGT |
Fulgent Genetics, Inc.
This page
|
43,234 | $687,420 | |
| 6 | RVTY |
Revvity, Inc.
|
7,772 | $680,904 |
All Filings in FLGT
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $687,420 | 43,234 | Shares | Other | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||